Prospective Validation Study of a Uterine Fibroid-Related Infertility Prediction Model
1 other identifier
observational
7,084
0 countries
N/A
Brief Summary
Female fertility may be affected by uterine fibroids, although this association has not been elucidated. Our retrospective study has already constructed a predictive model for infertility risk in patients with uterine fibroids using machine learning. We will now validate and optimize this model through a prospective study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2025
CompletedFirst Posted
Study publicly available on registry
September 17, 2025
CompletedStudy Start
First participant enrolled
September 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2031
September 17, 2025
September 1, 2025
6 years
August 19, 2025
September 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The pregnancy rate of women with uterine fibroids.
Fibroid types range from 0 to 8 according to the FIGO classification. The pregnancy rate varies with different types and size of fibroids. Subserosal fibroids do not exert any detrimental effects on fertility outcomes. Submucosal fibroids have negatively impact fertility. The effect of intramural fibroids on reproductive outcome has been a subject of debate in the past, but recent literature indicates that intramural myomas also negative impact fertility.The pregnancy rate among patients with uterine fibroids is calculated as the proportion of those who achieve pregnancy relative to the total number of patients with uterine fibroids.
through study completion, an average of 5 years
Secondary Outcomes (6)
The rate of spontaneous abortion of women with uterine fibroids.
through study completion, an average of 5 years
The rate of preterm birth of women with uterine fibroids.
through study completion, an average of 5 years
The rate of cesarean section of women with uterine fibroids.
through study completion, an average of 5 years
The rate of placental abruption of women with uterine fibroids.
through study completion, an average of 5 years
The rate of postpartum hemorrhage of women with uterine fibroids.
through study completion, an average of 5 years
- +1 more secondary outcomes
Study Arms (2)
UFs with infertile patients
Uterine fibroids combined with infertile women
UFs with non-infertile patients
Uterine fibroids combined with non-infertile women
Interventions
This study is a retrospective observational study without intervention.
Eligibility Criteria
Female patients with uterine fibroids
You may qualify if:
- Women aged 20-50 years with recent desires for conception. Diagnosed with uterine fibroids via ultrasound or pathology. Complete clinical records available. Ability to provide informed consent.
You may not qualify if:
- Active severe infectious or rheumatologic autoimmune diseases. History of malignant tumors. Incomplete clinical records. Unable to contact via phone or refusal to participate in follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tongji Hospitallead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 19, 2025
First Posted
September 17, 2025
Study Start
September 30, 2025
Primary Completion (Estimated)
September 30, 2031
Study Completion (Estimated)
September 30, 2031
Last Updated
September 17, 2025
Record last verified: 2025-09